Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis

Thorax

Volumn 69, Issue 8, 2014, Pages 740-745

  Knibbs, Luke D ^a,b   Johnson, Graham R ^a   Kidd, Timothy J ^b   Cheney, Joyce ^b,c   Grimwood, Keith ^b   Kattenbelt, Jacqueline A ^b   O'Rourke, Peter K ^d   Ramsay, Kay A ^b   Sly, Peter D ^b   Wainwright, Claire E ^b,c   Wood, Michelle E ^e   Morawska, Lidia ^a   Bell, Scott C ^b,e  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AIR CONDITIONING; AIRBORNE BACTERIUM; ARTICLE; ASPERGILLUS; BACTERIAL COUNT; BACTERIAL LOAD; BACTERIAL VIABILITY; BACTERIUM DETECTION; BREATHING MUSCLE; CANDIDA; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG FUNCTION; MALE; MUSCLE STRENGTH; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCEDOSPORIUM; SECONDARY ORGANIC AEROSOL; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TRICHOSPORON;

BACTERIAL INFECTION; CYSTIC FIBROSIS; INFECTION CONTROL; RESPIRATORY INFECTION;

ADOLESCENT; ADULT; AEROSOLS; CASE-CONTROL STUDIES; COUGH; CYSTIC FIBROSIS; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; SPUTUM;

EID: 84904055679     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205213     Document Type: Article

References (36)

1. Birnbaum HG, Morley M, Greenberg PE, et al. Economic burden of respiratory infections in an employed population. Chest 2002;122:603-11. (Pubitemid 35002143)
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
3. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35(10 Suppl 2):S65-164.
4. Li Y, Leung GM, Tang JW, et al. Role of ventilation in airborne transmission of infectious agents in the built environment- A multidisciplinary systematic review. Indoor Air 2007;17:2-18. (Pubitemid 46178282)
5. Jones-Lopez EC, Namugga O, Mumbowa F, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection: A household contact study. Am J Respir Crit Care Med 2013;187:1007-15.
6. Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012;206:902-6.
7. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009;373:1891-904.
8. Courtney JM, Bradley J, McCaughan J, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol 2007;42:525-32. (Pubitemid 46870384)
9. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704. (Pubitemid 32417671)
10. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 2012;40:227-38.
11. Kidd TJ, Ramsay KA, Hu H, et al. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 2013;41:1091-100.
12. Armstrong DS, Nixon GM, Carzino R, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002;166:983-7. (Pubitemid 35193230)
13. Cystic Fibrosis Australia. Infection control guidelines for cystic fibrosis patients and carers. 2nd ed. Sydney: Cystic Fibrosis Australia, 2012:13.
14. Saiman L. Infection prevention and control in cystic fibrosis. Curr Opin Infect Dis 2011;24:390-5.
15. Griffiths AL, Jamsen K, Carlin JB, et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005;171:1020-5. (Pubitemid 40616952)
16. Jones AM, Dodd ME, Govan JR, et al. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center. Am J Respir Crit Care Med 2005;171:257-60.
17. Wainwright CE, France MW, O'Rourke P, et al. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax 2009;64:926-31.
18. Jones AM, Govan JR, Doherty CJ, et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 2003;58:525-7. (Pubitemid 36714016)
19. Panagea S, Winstanley C, Walshaw MJ, et al. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 2005;59:102-7. (Pubitemid 40058035)
20. Clifton IJ, Fletcher LA, Beggs CB, et al. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. J Cyst Fibros 2010;9:64-8.
21. Clifton IJ, Fletcher LA, Beggs CB, et al. A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. BMC Microbiol 2008;8:105.
22. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68. (Pubitemid 41632054)
23. Morawska L, Johnson G, Ristovski Z, et al. Size distribution and sites of origin of droplets expelled during expiratory activities. J Aerosol Sci 2009;40: 256-69.
24. Goldberg LJ. Naval biomedical research laboratory, programmed environment, aerosol facility. Appl Microbiol 1971;21:244-52.
25. Knibbs LD, Morawska L, Bell SC, et al. Room ventilation and the risk of airborne infection transmission in 3 health care settings within a large teaching hospital. Am J Infect Control 2011;39:3546-51.
26. Aaron SD, Van de mheen KL, Ramotar K, et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 2010;304:2145-53.
27. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006;12:1657-62. (Pubitemid 44674240)
28. Beggs CB, Kerr KG, Noakes CJ, et al. The ventilation of multiple-bed hospital wards: review and analysis. Am J Infect Control 2008;36:250-9. (Pubitemid 351608718)
29. Sehulster LM, Chinn RYW, Arduino MJ, et al. Guidelines for environmental infection control in health-care facilities. Recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Chicago: American Society for Healthcare Engineering/American Hospital Association, 2004.
30. Nardell EA, Bucher SJ, Brickner PW, et al. Safety of upper-room ultraviolet germicidal air disinfection for room occupants: results from the Tuberculosis Ultraviolet Shelter Study. Public Health Rep 2008;123:52-60.
31. Centers for Disease Control and Prevention. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR 2005;54(RR-17):1-144.
32. Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: A retrospective cohort study. Lancet 2013;381:1551-60.
33. Gralton J, Tovey ER, McLaws ML, et al. Respiratory virus RNA is detectable in airborne and droplet particles. J Med Virol 2013;85:2151-9.
34. Jain M, Saiman LM, Sabadosa K, et al. Point: Does the risk of cross-infection warrant exclusion of adults with cystic fibrosis from Cystic Fibrosis Foundation events? Yes. Chest 2013;145:678-80.
35. Shepherd SL, Goodrich EJ, Desch J, et al. Counterpoint: Does the risk of cross-infection warrant exclusion of adults with cystic fibrosis from Cystic Fibrosis Foundation events? No. Chest 2013;145:680-3.
36. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient- To-patient transmission. Infect Control Hosp Epidemiol 2003;24(5 Suppl):S6-52.